{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:46:28Z","timestamp":1792813588484,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T00:00:00Z","timestamp":1608249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T00:00:00Z","timestamp":1608249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Despite efforts to improve tuberculosis (TB) detection, limitations in access, quality and timeliness of diagnostic services in low- and middle-income countries are challenging for current TB diagnostics. This study aimed to identify and characterise a metabolic profile of TB in urine by high-field nuclear magnetic resonance (NMR) spectrometry and assess whether the TB metabolic profile is also detected by a low-field benchtop NMR spectrometer. We included 189 patients with tuberculosis, 42 patients with pneumococcal pneumonia, 61 individuals infected with latent tuberculosis and 40 uninfected individuals. We acquired the urine spectra from high and low-field NMR. We characterised a TB metabolic fingerprint from the Principal Component Analysis. We developed a classification model from the Partial Least Squares-Discriminant Analysis and evaluated its performance. We identified a metabolic fingerprint of 31 chemical shift regions assigned to eight metabolites (aminoadipic acid, citrate, creatine, creatinine, glucose, mannitol, phenylalanine, and hippurate). The model developed using low-field NMR urine spectra correctly classified 87.32%, 85.21% and 100% of the TB patients compared to pneumococcal pneumonia patients, LTBI and uninfected individuals, respectively. The model validation correctly classified 84.10% of the TB patients. We have identified and characterised a metabolic profile of TB in urine from a high-field NMR spectrometer and have also detected it using a low-field benchtop NMR spectrometer. The models developed from the metabolic profile of TB identified by both NMR technologies were able to discriminate TB patients from the rest of the study groups and the results were not influenced by anti-TB treatment or TB location. This provides a new approach in the search for possible biomarkers for the diagnosis of TB.<\/jats:p>","DOI":"10.1038\/s41598-020-78999-4","type":"journal-article","created":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T11:04:12Z","timestamp":1608289452000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Discovery and validation of an NMR-based metabolomic profile in urine as TB biomarker"],"prefix":"10.1038","volume":"10","author":[{"given":"Jos\u00e9 Luis","family":"Izquierdo-Garcia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Comella-del-Barrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram\u00f3n","family":"Campos-Olivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Villar-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Prat-Aymerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luiza","family":"De Souza-Galv\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Angeles","family":"Jim\u00e9nez-Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Ruiz-Manzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoran","family":"Stojanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adela","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Serra-Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Garc\u00eda-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Muriel-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan Pau","family":"Millet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israel","family":"Molina-Pinargote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Casas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fina","family":"Sabri\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Martos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Herzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Ruiz-Cabello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,18]]},"reference":[{"key":"78999_CR1","unstructured":"World Health Organization. Global Tuberculosis Report 2019. https:\/\/www.who.int\/tb\/publications\/global_report\/en\/ (2019)."},{"key":"78999_CR2","doi-asserted-by":"publisher","first-page":"4188","DOI":"10.1128\/JCM.02283-12","volume":"50","author":"GE Pfyffer","year":"2012","unstructured":"Pfyffer, G. E. & Wittwer, F. Incubation time of mycobacterial cultures: How long is long enough to issue a final negative report to the clinician?. J. Clin. Microbiol. 50, 4188\u20134189 (2012).","journal-title":"J. Clin. Microbiol."},{"key":"78999_CR3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S1473-3099(12)70232-3","volume":"13","author":"JL Davis","year":"2013","unstructured":"Davis, J. L., Cattamanchi, A., Cuevas, L. E., Hopewell, P. C. & Steingart, K. R. Diagnostic accuracy of same-day microscopy versus standard microscopy for pulmonary tuberculosis: A systematic review and meta-analysis. Lancet Infect. Dis. 13, 147\u2013154 (2013).","journal-title":"Lancet Infect. Dis."},{"key":"78999_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-37186-2","volume":"9","author":"ZZ Qin","year":"2019","unstructured":"Qin, Z. Z. et al. Using artificial intelligence to read chest radiographs for tuberculosis detection: A multi-site evaluation of the diagnostic accuracy of three deep learning systems. Sci. Rep. 9, 1\u201310 (2019).","journal-title":"Sci. Rep."},{"key":"78999_CR5","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S1473-3099(13)70008-2","volume":"13","author":"SD Lawn","year":"2013","unstructured":"Lawn, S. D. et al. Advances in tuberculosis diagnostics: The Xpert MTB\/RIF assay and future prospects for a point-of-care test. Lancet Infect. Dis. 13, 349\u2013361 (2013).","journal-title":"Lancet Infect. Dis."},{"key":"78999_CR6","unstructured":"WHO. Automated Real-Time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB\/RIF Assay for the Diagnosis of Pulmonary and Extrapulmonary TB in Adults and Children: Policy update. World Health Organ. 1\u201379 (2013) ISBN: 978 92 4 150633 5."},{"key":"78999_CR7","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/S1473-3099(17)30691-6","volume":"18","author":"SE Dorman","year":"2018","unstructured":"Dorman, S. E. et al. Xpert MTB\/RIF ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: A prospective multicentre diagnostic accuracy study. Lancet Infect. Dis. 18, 76\u201384 (2018).","journal-title":"Lancet Infect. Dis."},{"key":"78999_CR8","first-page":"1","volume":"3099","author":"G Walzl","year":"2018","unstructured":"Walzl, G. et al. Series tuberculosis 2 tuberculosis: Advances and challenges in development of new diagnostics and biomarkers. Lancet Infect. Dis. 3099, 1\u201312 (2018).","journal-title":"Lancet Infect. Dis."},{"key":"78999_CR9","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.2217\/14622416.8.9.1243","volume":"8","author":"DI Ellis","year":"2007","unstructured":"Ellis, D. I., Dunn, W. B., Griffin, J. L., Allwood, J. W. & Goodacre, R. Metabolic fingerprinting as a diagnostic tool. Pharmacogenomics 8, 1243\u20131266 (2007).","journal-title":"Pharmacogenomics"},{"key":"78999_CR10","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1007\/s00134-019-05634-w","volume":"45","author":"JL Izquierdo-Garc\u00eda","year":"2019","unstructured":"Izquierdo-Garc\u00eda, J. L., Nin, N., Cardinal-Fernandez, P., Ruiz-Cabello, J. & Lorente, J. \u00c1. Metabolomic profile of acute respiratory distress syndrome of different etiologies. Intensive Care Med. 45, 1318\u20131320 (2019).","journal-title":"Intensive Care Med."},{"key":"78999_CR11","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1513\/AnnalsATS.201505-279PS","volume":"12","author":"M Mirsaeidi","year":"2015","unstructured":"Mirsaeidi, M., Banoei, M. M., Winston, B. W. & Schraufnagel, D. E. Metabolomics: Applications and promise in mycobacterial disease. Ann. Am. Thorac. Soc. 12, 1278\u20131287 (2015).","journal-title":"Ann. Am. Thorac. Soc."},{"key":"78999_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-016-0583-9","volume":"14","author":"CT Haas","year":"2016","unstructured":"Haas, C. T., Roe, J. K., Pollara, G., Mehta, M. & Noursadeghi, M. Diagnostic \u2018omics\u2019 for active tuberculosis. BMC Med. 14, 1\u20139 (2016).","journal-title":"BMC Med."},{"key":"78999_CR13","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1021\/acs.jproteome.5b00885","volume":"15","author":"AH Emwas","year":"2016","unstructured":"Emwas, A. H. et al. Recommendations and standardization of biomarker quantification using NMR-based metabolomics with particular focus on urinary analysis. J. Proteome Res. 15, 360\u2013373 (2016).","journal-title":"J. Proteome Res."},{"key":"78999_CR14","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1038\/nprot.2007.376","volume":"2","author":"O Beckonert","year":"2007","unstructured":"Beckonert, O. et al. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat. Protoc. 2, 2692\u20132703 (2007).","journal-title":"Nat. Protoc."},{"key":"78999_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/ht8010002","volume":"8","author":"BC Percival","year":"2019","unstructured":"Percival, B. C. et al. Low-field, benchtop NMR spectroscopy as a potential tool for point-of-care diagnostics of metabolic conditions: Validation, protocols and computational models. High-Throughput 8, 2 (2019).","journal-title":"High-Throughput"},{"key":"78999_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/metabo10040155","volume":"10","author":"J Leenders","year":"2020","unstructured":"Leenders, J. et al. Benchtop low-frequency 60 MHz NMR analysis of urine: A comparative metabolomics investigation. Metabolites 10, 1\u201313 (2020).","journal-title":"Metabolites"},{"key":"78999_CR17","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/0165-9936(89)85073-3","volume":"8","author":"NK Shah","year":"1989","unstructured":"Shah, N. K. & Gemperline, P. J. Program for calculating mahalanobis distances using principal component analysis. TrAC Trends Anal. Chem. 8, 357\u2013361 (1989).","journal-title":"TrAC Trends Anal. Chem."},{"key":"78999_CR18","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/978-1-4612-0919-5_4","volume-title":"Breakthroughs in Statistics: Foundations and Basic Theory","author":"H Hotelling","year":"1992","unstructured":"Hotelling, H. The generalization of student\u2019s ratio. In Breakthroughs in Statistics: Foundations and Basic Theory (eds Kotz, S. & Johnson, N. L.) 54\u201365 (Springer New York, New York, 1992). https:\/\/doi.org\/10.1007\/978-1-4612-0919-5_4."},{"key":"78999_CR19","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1093\/infdis\/jiu821","volume":"211","author":"CM Denkinger","year":"2015","unstructured":"Denkinger, C. M. et al. Defining the needs for next generation assays for tuberculosis. J. Infect. Dis. 211, S29\u2013S38 (2015).","journal-title":"J. Infect. Dis."},{"key":"78999_CR20","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/s41564-019-0380-2","volume":"4","author":"E MacLean","year":"2019","unstructured":"MacLean, E. et al. A systematic review of biomarkers to detect active tuberculosis. Nat. Microbiol. 4, 748\u2013758 (2019).","journal-title":"Nat. Microbiol."},{"key":"78999_CR21","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.diagmicrobio.2009.07.015","volume":"65","author":"I Latorre","year":"2009","unstructured":"Latorre, I. et al. Quantitative evaluation of T-cell response after specific antigen stimulation in active and latent tuberculosis infection in adults and children. Diagn. Microbiol. Infect. Dis. 65, 236\u2013246 (2009).","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"78999_CR22","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1513\/AnnalsATS.201408-394OC","volume":"12","author":"N Altet","year":"2015","unstructured":"Altet, N. et al. Predicting the development of tuberculosis with the tuberculin skin test and QuantiFERON testing. Ann. Am. Thorac. Soc. 12, 680\u2013688 (2015).","journal-title":"Ann. Am. Thorac. Soc."},{"key":"78999_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2019.01855","volume":"10","author":"P Comella-del-Barrio","year":"2019","unstructured":"Comella-del-Barrio, P. et al. A model based on the combination of IFN-\u03b3, IP-10, ferritin and 25-hydroxyvitamin D for discriminating latent from active tuberculosis in children. Front. Microbiol. 10, 1\u201315 (2019).","journal-title":"Front. Microbiol."},{"key":"78999_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-018-07635-7","volume":"9","author":"J Weiner","year":"2018","unstructured":"Weiner, J. et al. Metabolite changes in blood predict the onset of tuberculosis. Nat. Commun. 9, 1\u201312 (2018).","journal-title":"Nat. Commun."},{"key":"78999_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd009593.pub4","author":"DJ Horne","year":"2019","unstructured":"Horne, D. J. et al. Xpert MTB\/RIF and Xpert MTB\/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst. Rev. https:\/\/doi.org\/10.1002\/14651858.cd009593.pub4 (2019).","journal-title":"Cochrane Database Syst. Rev."},{"key":"78999_CR26","unstructured":"World Health Organization. High-Priority Target Product Profiles for New Tuberculosis Diagnostics: Report of a Consensus Meeting. (2014)."},{"key":"78999_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/JCM.01338-18","volume":"56","author":"GB Sigal","year":"2018","unstructured":"Sigal, G. B. et al. A novel sensitive immunoassay targeting the 5-methylthio-d-xylofuranose\u2013lipoarabinomannan epitope meets the WHO\u2019s performance target for tuberculosis diagnosis. J. Clin. Microbiol. 56, 1\u201317 (2018).","journal-title":"J. Clin. Microbiol."},{"key":"78999_CR28","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/S1473-3099(19)30001-5","volume":"19","author":"T Broger","year":"2019","unstructured":"Broger, T. et al. Novel lipoarabinomannan point-of-care tuberculosis test for people with HIV: A diagnostic accuracy study. Lancet Infect. Dis. 19, 852\u2013861 (2019).","journal-title":"Lancet Infect. Dis."},{"key":"78999_CR29","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/ejcn.2013.143","volume":"67","author":"MLH Hood","year":"2013","unstructured":"Hood, M. L. H. A narrative review of recent progress in understanding the relationship between tuberculosis and protein energy malnutrition. Eur. J. Clin. Nutr. 67, 1122\u20131128 (2013).","journal-title":"Eur. J. Clin. Nutr."},{"key":"78999_CR30","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/s41579-018-0013-4","volume":"16","author":"S Ehrt","year":"2018","unstructured":"Ehrt, S., Schnappinger, D. & Rhee, K. Y. Metabolic principles of persistence and pathogenicity in Mycobacterium tuberculosis. Nat. Rev. Microbiol. 16, 496\u2013507 (2018).","journal-title":"Nat. Rev. Microbiol."},{"key":"78999_CR31","doi-asserted-by":"publisher","first-page":"3825","DOI":"10.1038\/s41598-020-60669-0","volume":"10","author":"Y Cho","year":"2020","unstructured":"Cho, Y. et al. Identification of serum biomarkers for active pulmonary tuberculosis using a targeted metabolomics approach. Sci. Rep. 10, 3825 (2020).","journal-title":"Sci. Rep."},{"key":"78999_CR32","doi-asserted-by":"publisher","first-page":"159","DOI":"10.4103\/0366-6999.149188","volume":"128","author":"S Feng","year":"2015","unstructured":"Feng, S. et al. Analysis of serum metabolic profile by ultra-performance liquid chromatography-mass spectrometry for biomarkers discovery: Application in a pilot study to discriminate patients with tuberculosis. Chin. Med. J. Engl. 128, 159\u2013168 (2015).","journal-title":"Chin. Med. J. Engl."},{"key":"78999_CR33","doi-asserted-by":"publisher","first-page":"e40221","DOI":"10.1371\/journal.pone.0040221","volume":"7","author":"J Weiner","year":"2012","unstructured":"Weiner, J. et al. Biomarkers of inflammation, immunosuppression and stress with active disease are revealed by metabolomic profiling of tuberculosis patients. PLoS ONE 7, e40221 (2012).","journal-title":"PLoS ONE"},{"key":"78999_CR34","doi-asserted-by":"publisher","first-page":"4642","DOI":"10.1021\/pr4007359","volume":"12","author":"A Zhou","year":"2013","unstructured":"Zhou, A. et al. Application of 1H NMR spectroscopy-based metabolomics to sera of tuberculosis patients. J. Proteome Res. 12, 4642\u20134649 (2013).","journal-title":"J. Proteome Res."},{"key":"78999_CR35","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.tube.2015.02.038","volume":"95","author":"A Zhou","year":"2015","unstructured":"Zhou, A. et al. Metabolomics specificity of tuberculosis plasma revealed by 1H NMR spectroscopy. Tuberculosis 95, 294\u2013302 (2015).","journal-title":"Tuberculosis"},{"key":"78999_CR36","doi-asserted-by":"publisher","first-page":"e108854","DOI":"10.1371\/journal.pone.0108854","volume":"9","author":"JK Frediani","year":"2014","unstructured":"Frediani, J. K. et al. Plasma metabolomics in human pulmonary tuberculosis disease: A pilot study. PLoS ONE 9, e108854 (2014).","journal-title":"PLoS ONE"},{"key":"78999_CR37","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.1021\/acs.jproteome.6b00228","volume":"15","author":"L Sun","year":"2016","unstructured":"Sun, L. et al. Utility of novel plasma metabolic markers in the diagnosis of pediatric tuberculosis: A classification and regression tree analysis approach. J. Proteome Res. 15, 3118\u20133125 (2016).","journal-title":"J. Proteome Res."},{"key":"78999_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a021121","volume":"5","author":"DF Warner","year":"2015","unstructured":"Warner, D. F. Mycobacterium tuberculosis metabolism. Cold Spring Harb. Perspect. Med. 5, 1\u201323 (2015).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"78999_CR39","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.3390\/ijms20123094","volume":"20","author":"VA Popkov","year":"2019","unstructured":"Popkov, V. A., Silachev, D. N., Zalevsky, A. O., Zorov, D. B. & Plotnikov, E. Y. Mitochondria as a source and a target for uremic toxins. Int. J. Mol. Sci. 20, 3094 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"78999_CR40","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1099\/00221287-148-10-3069","volume":"148","author":"T Parish","year":"2002","unstructured":"Parish, T. & Stoker, N. G. The common aromatic amino acid biosynthesis pathway is essential in Mycobacterium tuberculosis. Microbiology 148, 3069\u20133077 (2002).","journal-title":"Microbiology"},{"key":"78999_CR41","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1099\/mic.0.000604","volume":"164","author":"SK Dolan","year":"2018","unstructured":"Dolan, S. K. et al. Loving the poison: The methylcitrate cycle and bacterial pathogenesis. Microbiology 164, 251\u2013259 (2018).","journal-title":"Microbiology"},{"key":"78999_CR42","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.cyto.2018.07.021","volume":"112","author":"A Leonard","year":"2018","unstructured":"Leonard, A. & Lalk, M. Infection and metabolism\u2014Streptococcus pneumoniae metabolism facing the host environment. Cytokine 112, 75\u201386 (2018).","journal-title":"Cytokine"},{"key":"78999_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2334-14-53","volume":"14","author":"S Mahapatra","year":"2014","unstructured":"Mahapatra, S. et al. A metabolic biosignature of early response to anti-tuberculosis treatment. BMC Infect. Dis. 14, 1\u201311 (2014).","journal-title":"BMC Infect. Dis."},{"key":"78999_CR44","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s11306-017-1261-4","volume":"13","author":"L Luies","year":"2017","unstructured":"Luies, L. et al. Urinary metabolite markers characterizing tuberculosis treatment failure. Metabolomics 13, 124 (2017).","journal-title":"Metabolomics"},{"key":"78999_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/5643853","volume":"2016","author":"M Eisenhut","year":"2016","unstructured":"Eisenhut, M. et al. Determination of urinary neopterin\/creatinine ratio to distinguish active tuberculosis from latent Mycobacterium tuberculosis infection. J. Biomarkers 2016, 1\u20136 (2016).","journal-title":"J. Biomarkers"},{"key":"78999_CR46","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.arbres.2010.02.010","volume":"46","author":"J Gonz\u00e1lez-Mart\u00edn","year":"2010","unstructured":"Gonz\u00e1lez-Mart\u00edn, J. et al. Documento de consenso sobre diagn\u00f3stico, tratamiento y prevenci\u00f3n de la tuberculosis. Arch. Bronconeumol. 46, 255\u2013274 (2010).","journal-title":"Arch. Bronconeumol."},{"key":"78999_CR47","doi-asserted-by":"publisher","first-page":"F54","DOI":"10.1152\/ajprenal.00315.2018","volume":"316","author":"JL Izquierdo-Garcia","year":"2019","unstructured":"Izquierdo-Garcia, J. L. et al. Identification of novel metabolomic biomarkers in an experimental model of septic acute kidney injury. Am. J. Physiol. Ren. Physiol. 316, F54\u2013F62 (2019).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"78999_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-10-363","volume":"10","author":"JL Izquierdo-Garc\u00eda","year":"2009","unstructured":"Izquierdo-Garc\u00eda, J. L. et al. A novel R-package graphic user interface for the analysis of metabonomic profiles. BMC Bioinform. 10, 1\u201310 (2009).","journal-title":"BMC Bioinform."},{"key":"78999_CR49","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1198\/tech.2003.s162","volume-title":"Multi- and Megavariate Data Analysis: Basic Principles and applications","author":"L Eriksson","year":"2013","unstructured":"Eriksson, L., Byrne, T., Johansson, E., Trygg, J. & Vikstr\u00f6m, C. Multi- and Megavariate Data Analysis: Basic Principles and applications 521 (Umetrics Acad, Ume\u00e5, 2013). https:\/\/doi.org\/10.1198\/tech.2003.s162."},{"key":"78999_CR50","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1037\/h0071325","volume":"24","author":"H Hotelling","year":"1933","unstructured":"Hotelling, H. Analysis of a complex of statistical variables into principal components. J. Educ. Psychol. 24, 417\u2013441 (1933).","journal-title":"J. Educ. Psychol."},{"key":"78999_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0079-6565(00)00036-4","volume":"39","author":"JC Lindon","year":"2001","unstructured":"Lindon, J. C., Holmes, E. & Nicholson, J. K. Pattern recognition methods and applications in biomedical magnetic resonance. Prog. Nucl. Magn. Reson. Spectrosc. 39, 1\u201340 (2001).","journal-title":"Prog. Nucl. Magn. Reson. Spectrosc."},{"key":"78999_CR52","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s11004-007-9141-5","volume":"40","author":"P Filzmoser","year":"2008","unstructured":"Filzmoser, P. & Hron, K. Outlier detection for compositional data using robust methods. Math. Geosci. 40, 233\u2013248 (2008).","journal-title":"Math. Geosci."},{"key":"78999_CR53","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1093\/nar\/gks1065","volume":"41","author":"DS Wishart","year":"2013","unstructured":"Wishart, D. S. et al. HMDB 3.0\u2014The human metabolome database in 2013. Nucleic Acids Res. 41, 801\u2013807 (2013).","journal-title":"Nucleic Acids Res."},{"key":"78999_CR54","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3390\/metabo2040775","volume":"2","author":"M Vinaixa","year":"2012","unstructured":"Vinaixa, M. et al. A guideline to univariate statistical analysis for LC\/MS-based untargeted metabolomics-derived data. Metabolites 2, 775\u2013795. https:\/\/doi.org\/10.3390\/metabo2040775 (2012).","journal-title":"Metabolites"},{"key":"78999_CR55","doi-asserted-by":"crossref","unstructured":"Ding, B. & Gentleman, R. Classification using generalized partial least squares. J. Comput. Graph. Stat. 14, 280\u2013298 (2005).","DOI":"10.1198\/106186005X47697"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78999-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78999-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78999-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:55:43Z","timestamp":1670374543000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78999-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,18]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["78999"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-78999-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,18]]},"assertion":[{"value":"21 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Jos\u00e9 Luis Izquierdo-Garcia, Patricia Comella-del-Barrio, Cristina Prat-Aymerich, and Jos\u00e9 Dom\u00ednguez are registered as inventors on a patent filed by the Institut d\u2019Investigaci\u00f3 Germans Trias i Pujol and CIBERES, disclosing the use of NMR-based urine metabolomic profile for TB diagnosis. Ram\u00f3n Campos-Olivas, Raquel Villar-Hern\u00e1ndez, Maria Luiza De Souza-Galv\u00e3o, Mar\u00eda A Jim\u00e9nez, Juan Ruiz-Manzano, Zoran Stojanovic, Adela Gonz\u00e1lez, Mar Serra-Vidal, Esther Garc\u00eda-Garc\u00eda, Beatriz Muriel-Moreno, Joan Pau Millet, Israel Molina-Pinargote, Xavier Casas, Javier Santiago, Fina Sabri\u00e1, Carmen Martos, Christian Herzmann, and Jes\u00fas Ruiz-Cabello declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22317"}}